Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonistW. Conrad Liles, David C. Dale, Hal E. Broxmeyer et al.|Blood|2003Cited by 717
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic MalignanciesMohamed L. Sorror, Rainer Storb, Brenda M. Sandmaier et al.|JAMA|2011Cited by 320
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)Nicolaus Kröger, Théo de Witte, Xavier Poiré et al.|Journal of Clinical Oncology|2017Cited by 248
Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell TransplantationRainer Storb, Brenda M. Sandmaier, Boglarka Gyurkocza et al.|Journal of Clinical Oncology|2013Cited by 212
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow TransplantationMohamad Mohty, Rafael F. Duarte, Kai Hübel et al.|Bone Marrow Transplantation|2014Cited by 192